Relacorilant Active Not Recruiting Phase 2 Trials for Recurrent Primary Peritoneal Carcinoma / Recurrent Ovarian Cancer / Recurrent Fallopian Tube Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03776812Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer